Liver-Focused chemo boosts bile duct cancer treatment?
NCT ID NCT07304388
First seen Jan 07, 2026 · Last updated Jun 11, 2026 · Updated 23 times
Summary
This study looked at 96 people with advanced bile duct cancer that couldn't be removed by surgery. Researchers wanted to see if adding a liver-directed chemotherapy (HAIC) to a standard drug mix (Gemox, lenvatinib, and toripalimab) could help patients live longer without the cancer growing. The goal was to measure how many patients were still alive and cancer-free after 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.